UC San Francisco (Audio) UCTV
-
- Science
Programs from the University of California, San Francisco.
-
Prostate Cancer and Androgen Deprivation Therapy
As part of the 2024 Prostate Cancer Patient Conference, Dr. Eric Small reviews Androgen Deprivation Therapy, including choices of agents, side effects, considerations in timing, duration, intensity of therapy, and discusses interpretation of clinical trial results.
Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 39756] -
Risk Assessment of PSA Recurrent Prostate Cancer
As part of the 2024 Prostate Cancer Patient Conference, Dr. Mack Roach discusses the phenomenon of “biochemical recurrence” and approaches to risk assessment, following treatments for localized prostate cancer.
Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 39761] -
Radiation Therapy for Prostate Cancer
As part of the 2024 Prostate Cancer Patient Conference, Dr. Julian Hong discusses radiation therapy as treatment for prostate cancer, including potential side effects, considerations in decision making, the radiation oncology care path.
Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 39759] -
Diet Exercise and Prostate Cancer
As part of the 2024 Prostate Cancer Patient Conference, Drs. June Chan and Stacey Kenfield present recommendations for diet and exercise based in research with prostate cancer patients. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 39767]
-
Barriers to Care for People with Developmental Disabilities
As part of the 2024 Developmental Disabilities Conference, three leaders of the disability community - Max Barrows, Matteo Musso, and Elizabeth Grigsby - provide insights into the barriers faced by people with disabilities to access healthcare. They review programmatic, communication and physical barriers and offer their ideas for solutions.
Series: "Developmental Disabilities Update" [Health and Medicine] [Show ID: 39740] -
Chemotherapy and Radioligand Therapy for Advanced Prostate Cancer
As part of the 2024 Prostate Cancer Patient Conference, Dr. Ivan de Kouchkovksky discusses the use of both chemotherapy and radioligand therapy, including a “theranostic” approach, in metastatic treatment resistant prostate cancer.
Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 39769]